Raltegravir treatment response in an HIV-2 infected patient: a case report

This publication has 5 references indexed in Scilit:

• Rapid and Durable Antiretroviral Effect of the HIV-1 Integrase Inhibitor Raltegravir as Part of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
• Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
  The Lancet, 2007
• Natural Polymorphisms in the Human Immunodeficiency Virus Type 2 Protease Can Accelerate Time to Development of Resistance to Protease Inhibitors
  Antimicrobial Agents and Chemotherapy, 2007
• Antiretroviral Drug Resistance in Non-Subtype B HIV-1, HIV-2 and Siv
  Antiviral Therapy, 2004
• Structure of HIV-2 reverse transcriptase at 2.35-Å resolution and the mechanism of resistance to non-nucleoside inhibitors
  Proceedings of the National Academy of Sciences, 2002